""

about | Maps & Directions | contact | admissions | faculty | alumni & development | library | Tech Support Center | dean's office | Policies & Procedures

department of medicine

Physician Scientist Pathway

joseph y. cheung, md, phdMessage from Joseph Y. Cheung, MD, PhD

Chair, Department of Medicine

Professor, Medicine

 

The Department of Medicine is instituting an exciting combined residency-fellowship program focused on training physician-scientists and future leaders in academic medicine. The goal of our program is to train first-rate physician-investigators who will be highly sought after as faculty members in academic institutions.

 

The program consists of 2 years of intensive Internal Medicine training, followed by 2-3 years of research (basic science or clinical investigation) training, and 1-2 years of clinical subspecialty training (2-2-2 pathway). The combined training will be offered for Internal Medicine/Cardiology, Internal Medicine/Hematology-Oncology, Internal Medicine/Pulmonary Medicine, and Internal Medicine/Infectious Diseases. There are currently three NIH T32 training grants (Cardiovascular Sciences, Thrombosis Research and NeuroAIDS), and trainees will be mentored by NIH-funded principal investigators during the research years.

 

For the 2-2-2 pathway, research training centers and directors at Temple University School of Medicine are:

  • Cardiology: Cardiovascular Research Center (Dr. Steven Houser) and Center of Translational Medicine (Dr. Walter Koch).

  • Hematology-Oncology: Fox Chase Cancer Center (Dr. Richard Fisher), Fels Institute (Dr. Jean-Pierre Issa) and Sol Sherry Thrombosis Center (Dr. David Essex).

  • Infectious Diseases: Comprehensive NeuroAIDS Center (Dr. Kamel Khalili).

  • Pulmonary Medicine: Center for Inflammation, Translational and Clinical Lung Research (Dr. Thomas Rogers) and Pulmonary Clinical Trials (Dr. Gerard Criner).

In addition, Temple Clinical Research Institute and Department of Clinical Sciences (Dr. Susan Fisher) will provide basic training curriculum in clinical investigation and biostatistics support for trainees during the research years.

 

On completion of the 2-2-2 pathway, the trainee will be Board eligible for Internal Medicine and the chosen Subspecialty. It is expected that trainees will have published in peer-reviewed journals and presented their research at National Meetings. The trainees will have developed a hypothesis-driven research project supported by preliminary data to submit competitive NIH K08 or K23. Please see additional information for more specifics regarding the areas of research interest of ABIM Research Pathway faculty.

 

Sincerely,

 

Joseph Y. Cheung, MD, PhD, FACP, FAHA

Member, American Society for Clinical Investigation